A New, One-Shot COVID-19 Vaccine
On April 13, 2021, the Centers for Disease Control and Prevention (CDC) and the U.S. Food and Drug Administration (FDA) recommended that health care providers temporarily stop using the Johnson & Johnson/Janssen (J&J) COVID-19 vaccine while they investigate reports of six people in the U.S. developing a rare and severe type of blood clot after receiving the J&J vaccine.
Out of an abundance of caution, Johns Hopkins Medicine will temporarily stop using the J&J vaccine pending CDC and FDA reviews.
Please read our full article. We will provide additional information as it becomes available.
(updated Apr. 15, 2021)